Demonstrating the ability to manufacture millions of doses of its “off-the-shelf” stem cell therapy product Progenza for first-in-human trials highlights the benefit of using adipose or fat tissue over other tissue types.
Regeneus is on track to start recruitment in the first half of this year for the clinical trial.
News: Regeneus hits key stem cell manufacturing milestone
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
